Test and media validations summary | |
Abbott RealTime SARS-CoV-2 Assay | |
Known Positive Samples Run | 68 |
Known Negative Samples Run | 59* |
Precision Runs | 4+and 4−samples daily over 5 days |
Limit of Detection (LOD) Study | Three replicates each at 1000, 500, 250, 70, 60, and 50 virus copies/ml |
Seven replicates each at manufacturer LOD of 100 virus copies/ml | |
Cepheid Xpert Xpress SARS-CoV-2 Assay | |
Known Samples Locally Run on Day 1 | 2+and 2−samples |
Known samples Locally Run on day 2 | 1+and 1−samples |
Intrafacility Viral Transport Media Emergency Usage | |
Sterility | Two 3 mL aliquots to be cultured per 500 mL of Hanks Balanced Salt Solution Base |
Initial Efficacy | Day 1: 3+and −samples refrigerated |
Day 2: 3+samples at room temperature, 3+samples in refrigerated, and 3 −samples refrigerated | |
Day 3: 3+samples and 3 −samples refrigerated, 3+samples frozen at −20 C then thawed | |
Ongoing Efficacy | 2+and 2 −samples per 500 mL of Hanks Balanced Salt Solution Base |
Phosphate Buffered Saline Media Emergency usage | |
Abbott RealTime SARS-CoV-2 Assay | ten known samples after 6 hour incubation (half +/−) |
ten known samples after 12 hours incubation (half +/−) | |
ten known samples after 24 hours incubation (half +/−) | |
ten known samples after 48 hours incubation (half +/−) | |
Cepheid Xpert Xpress SARS-CoV-2 Assay | ten known samples after 6 hour incubation (half +/−) |
All samples run for the validation reacted or had results as expected.
*One negative sample was quantity not sufficient, and so 58 known negative sample results were available for the validation.
−, negative; +, positive; VAMC, Veteran Affairs Medical Center.